GeminIQ Website Logo

Viewing INLB free

Subscribe for full history, 90+ metrics, screener, watchlist...

Item 9 Labs Corp.

INLB

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Cash
0000000104201
Accounts Receivable Net Current
1111112123101
Deferred Costs Current
--------86323
Assets Current
Assets Current
3434678101114734
Inventory Net
23224556---2-
Prepaid Expense And Other Assets
0000111112100
Property Plant And Equipment Net
252523212624191198877
Operating Lease Right Of Use Asset
0111110000000
Equity Method Investments
------------0
Deposits Assets Current
--------11211
Receivables Net Current
--------00000
Other Assets
----11-------
Accounts And Notes Receivable Net
--------00000
Deferred Sales Commission
------00-----
Escrow Deposit
55889101318-----
Deposits Assets Noncurrent
000000-1---1-
Other Assets Noncurrent
3441---1-----
Assets Held For Sale Not Part Of Disposal Group
7777---------
Intangible Assets Net Excluding Goodwill
1111111219201819127129888
Goodwill
585858585858585811111
Assets
112114115111121121117117150153262122
Liabilities And Stockhold…
Accounts Payable Current
7766664444322
Employee Related Liabilities Current
2112232301020
Accounts Payable And Other Accrued Liabilities Cur…
------------0
Interest Payable Current
8643222111111
Accrued Liabilities Current
2243212133201
Deferred Revenue Current
000000001----
Notes Payable Current
302221162521451223-
Liabilities Current
Liabilities Current
5947474139361615111210108
Accrued Income Taxes Current
----00------0
Short Term Non Bank Loans And Notes Payable
------------3
Taxes Payable Current
0000---------
Operating Lease Liability Current
0000000000000
Convertible Notes Payable Current
4344332111220
Deferred Tax Liabilities Interests In Financial As…
6666--6------
Deferred Revenue Noncurrent
00000001-----
Operating Lease Liability Noncurrent
0101110000000
Convertible Long Term Notes Payable
-10-----0----
Notes Payable
--------3322-
Long Term Debt Noncurrent
-777121615---23
Liabilities
59565449423833311415131311
Common Stock Value
0000000000000
Stockholders Equity
Stockholders Equity
535860627883848613613813811
Additional Paid In Capital
144143142140138137135133174176514430
Retained Earnings Accumulated Deficit
-78-72-68-65-47-41-37-34-25-24-24-23-16
Stockholders Equity Before Treasury Stock
--------149152---
Treasury Stock Value
-13-13-13-13-13-13-13-13-13-13-13-13-3
Minority Interest
-0-0-0-000-------
Liabilities And Stockholders Equity
112114115111121121117117150153262122
Allowance For Doubtful Accounts Receivable Current
--------0000-
Debt Instrument Unamortized Discount Current
--------11110
Common Stock Par Or Stated Value Per Share
0000000000000
Common Stock Shares Authorized
2,0002,0002,0002,0002,0002,0002,0002,0002,0002,0002,0002,0002,000
Common Stock Shares Issued
115114112110109110110107105104756864
Shares Outstanding
10210210098969898959292685661

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2023-25.00%-62.50%-80.00%120.00%20.00%-51.50%-23.53%-55.88%-82.06%---
2022-13.41%-11.87%-23.37%-18.69%-28.16%2.11%-38.67%-49.33%-71.00%-22.08%-23.64%-48.05%
2021-2.33%7.87%2.04%-3.33%-14.44%-44.44%0.00%-5.88%-19.41%19.07%13.40%23.71%
2020---------50.71%63.51%70.14%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
0.06
0.08
0.06
0.09
0.14
0.19
0.53
0.67
1.09
1.17
0.69
0.28
0.53
Quick Ratio
0.02
0.02
0.02
0.03
0.04
0.06
0.20
0.25
1.09
1.17
0.69
0.07
0.53
Working Capital
-55.47M
-43.45M
-43.73M
-37.03M
-33.78M
-28.72M
-7.35M
-4.89M
917.72K
2.02M
-3.26M
-7.40M
-3.97M
Leverage & Debt
Debt to Equity
1.13
0.98
0.90
0.79
0.54
0.46
0.39
0.36
0.11
0.11
0.97
1.58
1.04
Interest Coverage TTM
-2.19
-2.67
-3.28
-3.60
-1.92
-1.66
-1.27
-1.06
-0.54
-0.48
-0.67
-0.78
-3.71
Debt Ratio
0.53
0.49
0.47
0.44
0.35
0.32
0.28
0.26
0.10
0.10
0.49
0.61
0.51
Efficiency & Turnover
Asset Turnover TTM
0.17
0.17
0.18
0.19
0.18
0.19
0.35
0.32
0.21
0.16
0.47
0.46
0.43
Days Sales Outstanding TTM
14.45
16.50
19.73
17.07
20.26
26.67
22.39
14.98
26.46
41.14
34.53
17.74
20.33
Receivables Turnover TTM
25.25
22.11
18.50
21.39
18.02
13.69
16.30
24.36
13.80
8.87
10.57
20.57
17.95
Per Share Metrics
Diluted EPS TTM
-0.30
-0.30
-0.31
0.16
-0.23
-0.18
-0.14
0.11
-0.10
-0.12
-
-
-
Free Cash Flow Per Share TTM
-0.03
-0.05
-0.07
-0.10
-0.08
-0.09
-0.09
-0.11
-0.10
-0.09
-0.04
-0.02
-0.05
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
49.79%
43.75%
36.62%
33.61%
33.41%
36.19%
38.19%
39.26%
46.34%
47.83%
44.05%
40.58%
40.38%
Operating Profit Margin TTM
-102.37%
-107.35%
-109.43%
-106.01%
-59.79%
-41.62%
-29.38%
-25.53%
-17.33%
-22.91%
-47.67%
-66.81%
-129.71%
Net Profit Margin TTM
-157.71%
-156.21%
-151.07%
-143.31%
-91.16%
-66.76%
-52.53%
-49.71%
-49.01%
-70.42%
-118.39%
-151.44%
-158.45%
Growth Metrics
Net Revenue Growth (1Y)
-17.44%
-23.47%
-17.98%
-0.82%
29.88%
84.56%
160.52%
170.11%
104.16%
66.61%
47.42%
62.07%
421.60%
Net Income Growth (1Y)
42.83%
79.06%
135.89%
185.89%
141.61%
74.96%
15.59%
-11.33%
-36.86%
-27.62%
-7.55%
2.64%
333.40%
EPS Growth (1Y)
34.87%
68.78%
125.79%
134.81%
131.68%
20.98%
-8.34%
-22.90%
-56.36%
-32.51%
-21.72%
-4.41%
329.56%
Valuation Metrics
P/E TTM
-0.18
-0.33
-0.40
-1.21
-3.54
-7.52
-8.00
-11.46
-33.00
-23.66
-13.01
-8.33
-4.38
P/B TTM
0.10
0.18
0.21
0.61
0.98
1.55
1.25
1.45
2.19
1.67
11.23
12.79
5.70
P/S TTM
0.28
0.52
0.60
1.74
3.23
5.02
4.20
5.70
16.17
16.66
15.40
12.62
6.94
Market Cap
5.45M
10.11M
12.39M
37.80M
76.93M
128.62M
105.35M
124.96M
296.91M
231.24M
148.26M
102.50M
62.45M
Enterprise Value
39.17M
41.90M
43.93M
64.60M
105.74M
154.11M
126.96M
144.28M
302.43M
233.00M
153.36M
110.10M
64.68M
Calculated Values
Free Cash Flow TTM
-2.60M
-5.39M
-7.21M
-9.98M
-7.46M
-8.68M
-8.60M
-8.27M
-9.40M
-6.05M
-3.38M
-1.31M
-3.49M
Net Debt
33.72M
31.79M
31.54M
26.81M
28.81M
25.49M
21.61M
19.32M
5.51M
1.76M
5.10M
7.60M
2.23M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2014-08-21Purchase
Owner: Miller, Ronald L. Jr.
Title: -
Shares: 4,000
Price/Share: $0.17
Value: $680.00
Shares Owned: 50,023
Relationship: Director
Ownership: Direct
2014-05-19Purchase
Owner: Miller, Ronald L. Jr.
Title: -
Shares: 42,500
Price/Share: $0.12
Value: $5,100.00
Shares Owned: 44,500
Relationship: Director
Ownership: Indirect
2013-10-04Purchase
Owner: Miller, Ronald L. Jr.
Title: -
Shares: 1,000
Price/Share: $0.11
Value: $110.00
Shares Owned: 2,000
Relationship: Director
Ownership: Direct

Subscribe to unlock 17+ years of data

No institutional ownership data available.

Item 9 Labs Corp. (INLB) — SEC Financial Statements & Analysis

Item 9 Labs Corp. (INLB) is a dental equipment & supplies company, incorporated in DE. Item 9 Labs Corp. trades on OTC as: INLB. Based on its latest SEC filing (Form 10-Q, period ending 2023-06-30), Item 9 Labs Corp. reported a -17.44% year-over-year revenue growth, a Gross Profit Margin of 49.79% (TTM), a Debt-to-Equity ratio of 1.13x, a Price-to-Sales (P/S) ratio of 0.28x (TTM), a Price-to-Book (P/B) ratio of 0.10x (TTM), at a market cap of $5.45M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
-17.44%
Gross Profit Margin TTM
49.79%
Debt To Equity
1.13x
P/S TTM
0.28x
P/B TTM
0.10x
Market Cap
$5.45M

Data as of 2023-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Item 9 Labs Corp. in?

Item 9 Labs Corp. (INLB) operates in the Dental Equipment & Supplies industry.

What is INLB's market cap?

Item 9 Labs Corp. (INLB) has a market capitalization of $5.45M as of 2023-06-30.

What exchange does INLB trade on?

Item 9 Labs Corp. (INLB) trades on the OTC.

Where is Item 9 Labs Corp. incorporated?

Item 9 Labs Corp. is incorporated in DE.

Wall Street's data.
Main Street's price.